Donaldson Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Donaldson Capital Management's GILD Position: Q2 2026 in Review
Donaldson Capital Management increased its Gilead Sciences (GILD) stake by 7.8% in Q2 2026, buying an estimated $175K and bringing the position to 18,498 shares worth $2.34M. The position accounts for 0.07% of the portfolio, ranked #113.
Donaldson Capital Management first reported a position in GILD in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.39M in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Donaldson Capital Management held 18,498 shares of Gilead Sciences worth $2.34M as of Q2 2026.
- Donaldson Capital Management bought 1,331 Gilead Sciences shares in Q2 2026, an estimated $175K.
- Gilead Sciences made up 0.07% of Donaldson Capital Management's portfolio in Q2 2026, its #113 holding.
- Donaldson Capital Management first reported a position in Gilead Sciences in Q1 2021 and has held it in 22 quarters since.
- Donaldson Capital Management's Gilead Sciences position peaked at $2.39M in Q1 2026.
- 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Donaldson Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.